Camber Capital Management’s Myriad Genetics MYGN Stock Holding History

Camber Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.6M	Sell	2,000,000 -350,000	-15%	-$1.86M	1%	16
2025 Q1	$20.8M	Sell	2,350,000 -750,000	-24%	-$6.65M	0.74%	18
2024 Q4	$42.5M	Sell	3,100,000 -850,000	-22%	-$11.7M	0.98%	20
2024 Q3	$108M	Sell	3,950,000 -1,550,000	-28%	-$42.5M	3.44%	9
2024 Q2	$135M	Sell	5,500,000 -2,135,000	-28%	-$52.2M	3.72%	8
2024 Q1	$163M	Hold	7,635,000	–	–	3.99%	7
2023 Q4	$146M	Buy	7,635,000 +1,000,000	+15%	+$19.1M	3.72%	8
2023 Q3	$106M	Hold	6,635,000	–	–	3.51%	9
2023 Q2	$154M	Sell	6,635,000 -365,000	-5%	-$8.46M	5.01%	6
2023 Q1	$163M	Hold	7,000,000	–	–	5%	7
2022 Q4	$102M	Buy	7,000,000 +2,000,000	+40%	+$29M	3.48%	11
2022 Q3	$95.4M	Hold	5,000,000	–	–	2.92%	11
2022 Q2	$90.9M	Buy	5,000,000 +1,500,000	+43%	+$27.3M	3.94%	12
2022 Q1	$88.2M	Buy	3,500,000 +750,000	+27%	+$18.9M	3.19%	16
2021 Q4	$75.9M	Hold	2,750,000	–	–	2.61%	15
2021 Q3	$88.8M	Sell	2,750,000 -250,000	-8%	-$8.07M	2.73%	13
2021 Q2	$91.7M	Hold	3,000,000	–	–	3.09%	14
2021 Q1	$91.4M	Sell	3,000,000 -2,000,000	-40%	-$60.9M	3.13%	10
2020 Q4	$98.9M	Hold	5,000,000	–	–	3.47%	11
2020 Q3	$65.2M	Buy	5,000,000 +1,000,000	+25%	+$13M	3.44%	10
2020 Q2	$45.4M	Buy	4,000,000 +1,650,000	+70%	+$18.7M	2.6%	13
2020 Q1	$33.6M	Buy	2,350,000 +1,350,000	+135%	+$19.3M	2.01%	18
2019 Q4	$27.2M	Hold	1,000,000	–	–	1.39%	22
2019 Q3	$28.6M	Buy	+1,000,000	New	+$28.6M	1.51%	24
2018 Q3	–	Sell	-1,500,000	Closed	-$56.1M	–	27
2018 Q2	$56.1M	Hold	1,500,000	–	–	2.16%	19
2018 Q1	$44.3M	Hold	1,500,000	–	–	2.18%	19
2017 Q4	$51.5M	Sell	1,500,000 -500,000	-25%	-$17.2M	2.52%	13
2017 Q3	$72.4M	Sell	2,000,000 -1,000,000	-33%	-$36.2M	4.59%	6
2017 Q2	$77.5M	Sell	3,000,000 -1,325,000	-31%	-$34.2M	3.77%	8
2017 Q1	$83M	Buy	4,325,000 +265,000	+7%	+$5.09M	3.37%	6
2016 Q4	$67.7M	Buy	+4,060,000	New	+$67.7M	3.52%	10